Article Text

PDF
A novel mutation in the sulfate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia
  1. L Bonafé1,
  2. J Hästbacka2,
  3. A de la Chapelle2,3,
  4. A B Campos-Xavier1,
  5. C Chiesa1,
  6. A Forlino4,
  7. A Superti-Furga5,
  8. A Rossi4
  1. 1
    Division of Molecular Pediatrics, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
  2. 2
    Department of Medical Genetics and Hospital for Children and Adolescents, University of Helsinki, Finland
  3. 3
    Human Cancer Genetics Program, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA
  4. 4
    Department of Biochemistry “Alessandro Castellani”, University of Pavia, Pavia, Italy
  5. 5
    Centre for Pediatrics and Adolescent Medicine, Freiburg University Hospital, and Department of Pediatrics, University of Freiburg, Freiburg, Germany
  1. Dr Luisa Bonafé, Division of Molecular Pediatrics, Centre Hospitalier Universitaire Vaudois, Clinique Infantile 02-35, Av. P. Decker 2, 1011 – Lausanne, Switzerland; Luisa.Bonafe{at}chuv.ch

Abstract

Background: Mutations in the sulfate transporter gene SLC26A2 (DTDST) cause a continuum of skeletal dysplasia phenotypes that includes achondrogenesis type 1B (ACG1B), atelosteogenesis type 2 (AO2), diastrophic dysplasia (DTD), and recessive multiple epiphyseal dysplasia (rMED). In 1972, de la Chapelle et al reported two siblings with a lethal skeletal dysplasia, which was denoted “neonatal osseous dysplasia” and “de la Chapelle dysplasia” (DLCD). It was suggested that DLCD might be part of the SLC26A2 spectrum of phenotypes, both because of the Finnish origin of the original family and of radiographic similarities to ACG1B and AO2.

Objective: To test the hypothesis whether SLC26A2 mutations are responsible for DLCD.

Methods: We studied the DNA from the original DLCD family and from seven Finnish DTD patients in whom we had identified only one copy of IVS1+2T>C, the common Finnish mutation. A novel SLC26A2 mutation was found in all subjects, inserted by site-directed mutagenesis in a vector harbouring the SLC26A2 cDNA, and expressed in sulfate transport deficient Chinese hamster ovary (CHO) cells to measure sulfate uptake activity.

Results: We identified a hitherto undescribed SLC26A2 mutation, T512K, homozygous in the affected subjects and heterozygous in both parents and in the unaffected sister. T512K was then identified as second pathogenic allele in the seven Finnish DTD subjects. Expression studies confirmed pathogenicity.

Conclusions: DLCD is indeed allelic to the other SLC26A2 disorders. T512K is a second rare “Finnish” mutation that results in DLCD at homozygosity and in DTD when compounded with the milder, common Finnish mutation.

Statistics from Altmetric.com

Footnotes

  • ▸ An additional figure is published online only at http://jmg.bmj.com/content/vol45/issue12

  • Funding: This work has been supported by the Swiss National Research Foundation (grant 3100A0-100485 to LB and ASF), by the Telethon-Italy (grant GGP06076 to AR), by the European Community (FP6, “EuroGrow” project, LSHM-CT-2007-037471 to AR), and by the National Institutes of Health, USA (grant CA16058) to the Ohio State University Comprehensive Cancer Center. JH was supported by the Academy of Finland, The Sigrid Juselius Foundation and the Ulla Hjelt fund of the Finnish Pediatric Research Foundation.

  • Competing interests: None declared.

  • Ethics approval: Ethics committee approval has been obtained (from the University of Lausanne).

  • Patient consent: Parental/guardian consent obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.